California ACR 94: Relative to the Cal-Vet loan program.

Bill Text

• 

• 

• 

• 

• 

• 
 Bill Text - ACR-94 Antimicrobial resistance.

• 

• skip to content

• home

• accessibility

• FAQ

• feedback

• sitemap

• login

• x

 Quick Search:

 Bill Number
 Bill Keyword

• 

• 

• 

• 

• 

• Home

• Bill Information

• California Law

• Publications

• Other Resources

• My Subscriptions

• My Favorites

• Bill Information
 >>

• Bill Search
 >>

• Text

 Bill Text

 PDF2
 Bill PDF

 |Add To My Favorites |Track Bill | Version: 06/18/26 - Chaptered
 06/15/26 - Enrolled
 06/02/25 - Introduced

 ACR-94 Antimicrobial resistance.(2025-2026)

 Text

 >>

 Votes

 >>

 History
 >>

 Bill Analysis
 >>

 Today's Law As Amended
 >>

 Compare Versions
 >>

 Status
 >>

 Comments To Author

 >>

 Track Bill
 >>

 Add To My Favorites
 >>

 SHARE THIS:

ACR94:v97#DOCUMENTBill Start

 Assembly Concurrent Resolution

 No. 94

 CHAPTER 103

 Relative to antimicrobial resistance. 

 [
 Filed with

 Secretary of State
 June 18, 2026.
 ]

LEGISLATIVE COUNSEL'S DIGEST

ACR 94, Patel.
 Antimicrobial resistance.

This measure would, among other things, recognize antimicrobial resistance as a public health crisis requiring urgent and sustained action and urge specified state agencies to explore available funding mechanisms to support research and development initiatives addressing antimicrobial resistance, particularly in underserved and high-risk communities.

Digest Key

 Fiscal Committee:
 NO 

Bill Text

WHEREAS, Antimicrobial resistance (AMR) is a growing public health threat that undermines the effectiveness of life-saving medications, leading to an estimated 35,000 deaths annually in the United States, according to the federal Centers for Disease Control and Prevention (CDC); and

WHEREAS, AMR poses a significant public health challenge in California as, annually, the state experiences approximately 360,000 illnesses and nearly 4,500 deaths due to infections from antimicrobial-resistant pathogens; and

WHEREAS, Sixty percent of intensive care unit infections in the state demonstrate resistance to key antibiotics, particularly in urban areas and among vulnerable populations; and

WHEREAS, The overuse and misuse of antibiotics in human medicine, veterinary practices, and agriculture significantly contribute to the development of resistant microorganisms, making infections harder to treat and increasing the risk of the spread of disease, severe illness, and death; and

WHEREAS, A global action plan to tackle the growing problem of resistance to antibiotics and other antimicrobial medicines was endorsed at the 68th World Health Assembly in May 2015, with a key objective being to improve awareness and understanding of AMR through effective communication, education, and training; and

WHEREAS, November 18 to 24 of each year, inclusive, is World AMR Awareness Week, a global campaign that is recognized annually to improve awareness and understanding of AMR and encourage best practices among the public, stakeholders, and policymakers, who all play a critical role in reducing the further emergence and spread of AMR; and

WHEREAS, California is a leader in adopting policies to address AMR, including the enactment of Senate Bill 1311 (Chapter 843 of the Statutes of 2014) and Senate Bill 27 (Chapter 758 of the Statutes of 2015), which restricted the use of medically important antibiotics in livestock and was associated with a measurable 7.1 percent reduction in extended-spectrum cephalosporin resistance in human E. coli infections; and

WHEREAS, California state policy already mandates antimicrobial stewardship programs in hospitals and skilled nursing facilities, and supports surveillance, prevention, and education efforts to contain AMR, but further action is needed to close gaps in rural and underserved communities and to strengthen statewide coordination; and

WHEREAS, Rapid and accurate diagnostic testing is essential to reduce inappropriate antibiotic use, ensuring that patients receive effective treatment while limiting the spread of resistant bacteria and supporting California’s antimicrobial stewardship programs that have been recognized for improving patient outcomes and reducing resistance; and

WHEREAS, Medicaid programs provide health care coverage to millions of low-income Californians, making them critical stakeholders in addressing AMR through coverage policies and education initiatives that can reduce disparities in health outcomes; and

WHEREAS, Public and private stakeholders must collaborate to implement policies that encourage the development and use of innovative diagnostic tools and stewardship programs; and

WHEREAS, Effective action to combat AMR requires a multipronged approach that includes surveillance, prevention, education, research, and equitable access to health care; now, therefore, be it

Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Assembly of the State of California, the Senate thereof concurring, recognizes antimicro